[Comparison of antibacterial effect of rifampicin and cephaloridine on a model of E. coli pyelonephritis in rats].
D000208:Acute Disease; D000818:Animals; D001437:Bacteriuria / Q000188:drug therapy; D001522:Behavior, Animal / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002509:Cephaloridine / Q000627:therapeutic use*; D003864:Depression, Chemical; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D007668:Kidney / Q000033:anatomy & histology / Q000382:microbiology / Q000473:pathology; D009929:Organ Size; D011704:Pyelonephritis / Q000188:drug therapy* / Q000473:pathology; D051381:Rats; D012293:Rifampin / Q000627:therapeutic use*
D002509:Cephaloridine; D012293:Rifampin
Vergleich der antibakteriellen Wirkung von Rifampicin und Cephaloridin am Modell einer E. coli-Pyelonephritis bei Ratten.